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Introduction:  Angiosarcoma  is a  malignant  tumour  arising  from  endothelial  cells  that  accounts  for  1% of
all sarcomas.  The  sinonasal  site  of angiosarcoma  is exceptional.
Case  report:  The  authors  report a  case  of  sinonasal  angiosarcoma  in  a 53-year-old  man.  Despite  wideadiotherapy
resection  by  open  surgery  and  postoperative  chemoradiotherapy,  several  tumour  recurrences  were
observed,  requiring  multiple  operations.
Discussion:  Only  histological  examination  with  immunohistochemistry  is  able  to conﬁrm  the diagno-
sis  (factor  VIII,  CD34  and  CD31  antigens).  Standard  treatment  consists  of  surgery  with  wide resection
followed  by  radiotherapy.  The  authors  discuss  the  treatment  modalities  and  prognosis  of  this  tumour.
© 2015  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Sinonasal angiosarcoma accounts for 1% of all sarcomas [1].
he diagnosis of angiosarcoma can be suggested clinically in the
resence of a bleeding tumour with contrast enhancement on com-
uted tomography. However, the deﬁnitive diagnosis is based on
istology, systematically associated with immunohistochemistry
2].
. Case report
A 53-year-old diabetic and hypertensive man  consulted for min-
mal unilateral right epistaxis with mucopurulent nasal discharge
nd partially blocked nose. Endoscopy demonstrated a polypoid
ass of the right middle meatus with no palpable cervical lymph
odes. Complete resection of the mass was performed by endonasal
urgery. Histological examination concluded on capillary haeman-
ioma with no signs of malignancy. Three and a half months later,
he patient was reoperated by endonasal surgery for tumour recur-
ence in the right middle turbinate (Fig. 1) with right middle meatal
ntrostomy and anterior ethmoidectomy. Histological examination
omprising immunohistochemical staining was in favour of grade
I angiosarcoma. The patient was treated by postoperative con-
omitant chemoradiotherapy: 50 Gy of radiotherapy and 6 cycles of
isplatin. Nine months later, the patient presented another recur-
ence in the medial wall of the orbit and was again reoperated via an
ndonasal approach. Surgery consisted of radical ethmoidectomy
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879-7296/© 2015 Elsevier Masson SAS. All rights reserved.and was  followed by 3 cycles of cisplatin and epirubicin. Five
months after, a third recurrence in the left and right nasal cav-
ities was  resected via a lateral rhinotomy (Fig. 2), followed by
chemotherapy (9 cycles of paclitaxel). Ten months later, the patient
presented another naso-ethmoido-maxillary recurrence with no
intracranial or orbital invasion and was  reoperated via a lateral
rhinotomy. As this extensive resection exposed the meninges of the
anterior cranial fossa, the defect was  ﬁlled by a frontalis myofas-
cial ﬂap and the skin defect was  closed by a forehead ﬂap. Gamma
knife radiosurgery was then performed: 20 Gy to small residues on
the medial walls of the orbit and ethmoid sinus (Fig. 3). Six months
later, the patient presented with massive recurrence with exter-
nalisation of the tumour via the nostrils and surgical wound with
frontal intracranial extension on computed tomography. In view
of the cerebral extension of the tumour and the marked deteriora-
tion of the patient’s general state, the patient was considered to be
inoperable and died 10 days later.
3. Discussion
Angiosarcoma is a very rare malignant tumour accounting for
almost 1% of all sarcomas [1]. The sinonasal site is exceptional,
as only 24 cases have been reported since 1974 [2,3] in patients
ranging in age from 8 to 81 years (our patient was  53 years
old) with a male predominance (16 men  for 8 women in the 24
reported cases). No known aetiology or risk factors have been iden-
tiﬁed, but telangiectasia, trauma and chronic oedema have been
proposed [4,5]. Clinically, the tumour presents with similar symp-
toms to those of malignant sinonasal tumours: initially unilateral
rhinological syndrome (epistaxis, blocked nose and rhinorrhoea)
and, at a more advanced stage, tumour syndrome with invasion
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rFig. 1. Heterogeneously enhanced naso-ethmoidal tumour.
f vital structures (eyeball, brain and infratemporal fossa). Epis-
axis was the most common presenting complaint in the published
ases and in the case reported here. On imaging assessment, the
umour presents variable dimensions (ranging from 2 to 8 cm in
he published cases) with heterogeneous contrast enhancement
nd signs of bone destruction on CT scan. On MRI, the tumour
resents a low-intensity signal on T1-weighted sequences and
 heterogeneous high-intensity signal on T2-weighted sequences
ith intense, heterogeneous contrast enhancement. Histology withmmunohistochemical staining is the only way to conﬁrm the diag-
osis. Macroscopically, the tumour is polypoid, nodular, violaceous
ed with a friable appearance and zones of haemorrhagic necrosis.
Fig. 3. Postoperative GammFig. 2. Naso-ethmoid recurrence with heterogeneous high-intensity signal on the
T2-weighted sequence.
Histological examination reveals a tumour composed of branched
and anastomosed vascular structures lined by atypical endothe-
lial cells (classiﬁed in grades) with a ﬁbrous stroma containing
necrosis and haemosiderin deposits [6]. The case reported here
was classiﬁed as FNCLCC grade II (French cancer centre classiﬁca-
tion). Immunohistochemistry conﬁrmed the diagnosis by showing
positive staining for factor VIII, CD31 and CD34.
a  knife target volume.
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[8] Namyslowski G, Scierski W,  Turecka L, et al. A very rare case of low-
grade angiosarcoma of the nose and paranasal sinuses. Otolaryngol PolF. Es-Sbissi et al. / European Annals of Otorhinolar
The differential diagnosis includes haemangioma, intravascu-
ar papillary endothelial hyperplasia (Masson’s disease), juvenile
asopharyngeal angioﬁbroma, haemangiopericytoma, Kaposi’s
arcoma and malignant melanoma [6].
Treatment is based on surgery (adapted to the tumour site
nd extension) followed by radiotherapy. Other treatment modal-
ties have been tried, such as chemotherapy, radiosurgery (gamma
nife) [4], and interleukins [2–5]. However, no standardized thera-
eutic management has been deﬁned in view of the limited number
f published cases and the absence of comparative studies. The ﬁve-
ear survival rate is 22% (versus 12% for soft tissue angiosarcoma
f the head and neck) and depends on the grade of differentiation
f the tumour and the stage at diagnosis [7]. Distant metastases
ay  occur during the ﬁrst 24 months in 30% of cases; metastases
nvolve bone, lungs, liver, skin or uterine cervix [3]. In our patient,
he interval between diagnosis and death was almost 2 and a half
ears. The most commonly reported prognostic factors are: early
iagnosis, grade of differentiation, the patient’s age (over the age
f 50), tumour size and resectability [2,8,9].
. ConclusionSinonasal angiosarcoma is a rare tumour. It does not present
ny speciﬁc clinical features apart from its highly locally invasive
nd rapidly progressive nature. Only histological examination with
mmunohistochemistry can provide the deﬁnitive diagnosis.
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